Detecting Clostridium botulinum
http://www.100md.com
《传染病的形成》
Medical University Innsbruck, Innsbruck, Austria
C. botulinum comprises a heterogenous group of subspecies that produce botulinum neurotoxin (BoNT); identification and characterization usually rely on animal testing that focuses on antigenetically distinct toxins (2). Although strains of C. botulinum that do not produce toxins are sometimes isolated from wound infections not related to botulism, some strains of C. butyricum and C. baratii are also able to produce BoNTs.
The mouse bioassay is currently the accepted method for detecting BoNT. In this assay, mice that receive an intraperitoneal injection containing a sample with more than a minimum lethal dose show symptoms of botulinum intoxication and die. ELISAs, which recognize protein antigenic sites, are still less sensitive than the mouse bioassay (3).
Because the mouse bioassay requires euthanizing many animals, and results are not available for several hours, new diagnostic methods are needed. For C. botulinum, an organism widely dispersed in the environment, DNA-based methods may not provide the ultimate solution. Rapid methods to detect and differentiate active BoNTs, such as the rapid, mass spectrometry-based, functional method, are promising candidates to substitute for animal testing in the near future (4).
References
Song L, Ahn S, Walt DR. Detecting biological warfare agents. Emerg Infect Dis. 2005;11:1629–32.
Grif K, Dierich MP, Much P, Hofer E, Allerberger F. Identifying and subtyping species of dangerous pathogens by automated ribotyping. Diagn Microbiol Infect Dis. 2003;47:313–20.
Ferreira JL, Eliasberg SJ, Edmonds P, Harrison MA. Comparison of the mouse bioassay and enzyme-linked immunosorbent assay procedures for the detection of type A botulinal toxin in food. J Food Prot. 2004;67:203–6.
Barr JR, Moura H, Boyer AE, Woolfitt AR, Kalb SR, Pavlopoulos A, et al. Botulinum neurotoxin detection and differentiation by mass spectrometry. Emerg Infect Dis. 2005;11:1578–83.(Josef Karnerand Franz All)
C. botulinum comprises a heterogenous group of subspecies that produce botulinum neurotoxin (BoNT); identification and characterization usually rely on animal testing that focuses on antigenetically distinct toxins (2). Although strains of C. botulinum that do not produce toxins are sometimes isolated from wound infections not related to botulism, some strains of C. butyricum and C. baratii are also able to produce BoNTs.
The mouse bioassay is currently the accepted method for detecting BoNT. In this assay, mice that receive an intraperitoneal injection containing a sample with more than a minimum lethal dose show symptoms of botulinum intoxication and die. ELISAs, which recognize protein antigenic sites, are still less sensitive than the mouse bioassay (3).
Because the mouse bioassay requires euthanizing many animals, and results are not available for several hours, new diagnostic methods are needed. For C. botulinum, an organism widely dispersed in the environment, DNA-based methods may not provide the ultimate solution. Rapid methods to detect and differentiate active BoNTs, such as the rapid, mass spectrometry-based, functional method, are promising candidates to substitute for animal testing in the near future (4).
References
Song L, Ahn S, Walt DR. Detecting biological warfare agents. Emerg Infect Dis. 2005;11:1629–32.
Grif K, Dierich MP, Much P, Hofer E, Allerberger F. Identifying and subtyping species of dangerous pathogens by automated ribotyping. Diagn Microbiol Infect Dis. 2003;47:313–20.
Ferreira JL, Eliasberg SJ, Edmonds P, Harrison MA. Comparison of the mouse bioassay and enzyme-linked immunosorbent assay procedures for the detection of type A botulinal toxin in food. J Food Prot. 2004;67:203–6.
Barr JR, Moura H, Boyer AE, Woolfitt AR, Kalb SR, Pavlopoulos A, et al. Botulinum neurotoxin detection and differentiation by mass spectrometry. Emerg Infect Dis. 2005;11:1578–83.(Josef Karnerand Franz All)